AMRIXAL 30
Country: Iżrael
Lingwa: Ingliż
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
CYCLOBENZAPRINE HYDROCHLORIDE 30 MG
Disponibbli minn:
PHARMASWISS ISRAEL LTD
Kodiċi ATC:
M03BX08
Għamla farmaċewtika:
CAPSULES EXTENDED RELEASE
Rotta amministrattiva:
PER OS
Manifatturat minn:
APTALIS PHARMATECH INC, USA
Grupp terapewtiku:
CYCLOBENZAPRINE
Indikazzjonijiet terapewtiċi:
Amrixal is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, and limitation of motion.
Data ta 'l-awtorizzazzjoni:
2011-08-01
